Pharmaceutical Market in the United States : Overview
In 2011, the United States pharmaceuticals market is forecast to have a value of $332.8 billion, an increase of 27.6% since 2006. The compound annual growth rate of the market in the period 2006-2011 is predicted to be 5%.
|
Global OTC Pharmaceutical Market
In 2011, the global OTC pharmaceuticals market is forecast to have a value of $115.4 billion, an increase of 30.1% since 2006.
|
DAYTRANA™ (methylphenidate transdermal system) Provides Individualized Symptom Management
Shorter Wear Time Provides Shorter Duration of Effect, Offering Individualized ADHD Symptom Management
|
New Drug Approved for Parkinson's disease
New drug for Parkinson's disease, designed to block the breakdown of a chemical that contributes to problems with movement and coordination, launched in the U.S
|
Asthma/COPD Market: Overview
Global asthma/COPD sales expected to grow to over $30 billion by 2015.
|
FDA Approves New HIV Treatment for Patients Who Do Not Respond to Existing Drugs
Prezista™ Receives U.S. FDA Approval as Part of HIV Combination Therapy
|
Success of EU Pharmaceutical Industry to Depend on Proactive Regulatory Legislation
Fundamental drivers that will improve and strengthen the evolution of the drug discovery process in western and eastern Europe are yet more strict regulations, mandatory good manufacturing practice (GMP) compliance and improved legislations for clinical trials to create opportunities for an efficient competitive environment
|
Europe's 3rd largest drug maker offers 67% premium for biotech
Major pharmaceutical firms are battling to strengthen their position in the fast-growing market for biological drugs such as antibodies, with analysts forecasting sales of antibody-based drugs will more than double by 2010 from $14 billion in 2005.
|
Rx-to-OTC Switching Strategies
Lifecycle management and building brand equity in the US, EU and ROW
|
The world's 10 best-selling drugs
Forbes - For the first time ever, global spending on prescription drugs has topped $600 billion, even as growth slowed in Europe and North America.
|
|
|
